Landry Robert E — SEC Form 4 filings
SEC reporting owner CIK 1585160. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-17 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 2,000 shares, $146,790 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 1,000 shares @ $74.66 ($74,660) in CYTOKINETICS INC, filed 2026-09-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CYTOKINETICS INC (CYTK) | Director | 5 | — | 2 legs · 2,000 sh · $146,790 | 5 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | EVP Finance CFO | 5 | — | — | 18 |
| Zymeworks Inc. (ZYME) | Director | 2 | — | — | 3 |
Form 4 filings — Landry Robert E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 1,000 @ $72.13 | EDGAR |
| 2026-09-11 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 1,000 @ $74.66 | EDGAR |
| 2026-05-27 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 2,851 @ $0 · Grant/award (A): 4,301 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 11,500 (derivative) @ $0 · Grant/award (A): 7,700 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 62,000 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 7,333 @ $0 · Grant/award (A): 10,880 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 25,538 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 400 @ $378.98 · Tax withholding (F): 281 @ $956.65 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 400 @ $378.98 · Tax withholding (F): 282 @ $953.42 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $378.98 · Tax withholding (F): 776 @ $948.50 · Option exercise (M): 500 @ $378.98 · Tax withholding (F): 352 @ $951.26 · Option exercise (M): 1,100 (derivative) @ $0 · Option exercise (M): 500 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 500 @ $378.98 · Tax withholding (F): 354 @ $932.34 · Option exercise (M): 500 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 800 @ $378.98 · Tax withholding (F): 568 @ $928.18 · Option exercise (M): 800 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1585160 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →